SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab.
J Gastrointestin Liver Dis
; 30(2): 310-311, 2021 06 19.
Article
in English
| MEDLINE | ID: covidwho-1282748
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Skin Diseases
/
Adalimumab
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Gastrointestin Liver Dis
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS